Clinical Trials Logo

Bone Fibrous Dysplasia clinical trials

View clinical trials related to Bone Fibrous Dysplasia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02868645 Completed - Clinical trials for Bone Fibrous Dysplasia

Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia

PERIOSTINE
Start date: May 25, 2016
Phase: N/A
Study type: Interventional

Fibrous dysplasia is a rare bone disease which can cause pain and fractures. It has been shown that periostin is over expressed in fibrous component in patients bones ; but periostin has never been measured out in serum of patients, although it is easy to assess. This study aims to show whether serum periostin is elevated in serum of patients with fibrous dysplasia, and if it is more elevated in patients with severe forms of the disease.